| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 29,475,000 | 30,036,000 | 22,784,000 | 24,592,000 | | Cost of Revenue | (29,396,000) | 15,083,000 | 14,313,000 | 15,951,000 | | | Gross Profit |
-
| 14,953,000 | 8,471,000 | 8,641,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,541,000 | 9,223,000 | 10,526,000 | 8,013,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 46,997,000 | 429,000 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,841,000 | 5,301,000 | (2,055,000) | 628,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 5,333,000 | 5,301,000 | (2,055,000) | 628,000 | | Interest Expense | 494,000 | 510,000 | 488,000 | 480,000 | | Income Before Tax | 4,839,000 | 4,791,000 | (2,543,000) | 148,000 | | Income Tax Expense | 1,601,000 | 1,520,000 | (1,014,000) | (167,000) | | Minority Interest | (288,000) |
-
|
-
| (198,000) | | | | Net Income From Continuing Ops | 3,042,000 | 3,384,000 | (1,446,000) | 117,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,061,000 | 3,384,000 | (1,446,000) | 117,000 | | Preferred Stock And Other Adjustments | 177,000 | (89,000) | (88,000) |
-
| | | Net Income Applicable To Common Shares | $3,238,000 | $3,295,000 | ($1,534,000) | $117,000 |
|
0.02% Nasdaq 0.00%
Income Statement
